Ideas to Action:

Independent research for global prosperity

CGD Policy Blogs

 

Before Recommending the RTS,S Malaria Vaccine for Wider Use, WHO Should Address Three Key Considerations

Last month, the world woke up to promising news on malaria prevention: administering an existing malaria vaccine (RTS,S) in addition to antimalarial drugs before the rainy season reduced child hospitalizations and deaths by approximately 70 percent in Burkina Faso and Mali. These results arrived ahead of a forthcoming decision from the World Health Organization on whether to recommend RTS,S for broader use. This blog argues that WHO should consider value for money and address three key considerations before making their reccomendation.

An image of a woman with a Covid vaccine band aid.

Germany’s Role in Global Health After the September 2021 Election

Germany has stepped up as an important player in global health in recent years, rising to become the third largest government donor to health in 2019. Notably, Germany has played a key role in WHO reform efforts; it is the largest donor to WHO for the 2020-21 budget period, and one of the largest WHO emergency fund donors. Germany has also played a leading role politically, placing health on the agenda of the G-20 for the first time in 2017 and trying to tackle increasing global health fragmentation as co-initiator of the Global Action Plan.

Supplies being unloaded at a hospital in Donetsk. Photo by Aleksey Filippov / UNICEF

Retooling UNICEF: New Leadership Needs to Couple Humanitarian Imperatives with Systems Reform

UNICEF’s Executive Director, Henrietta Fore, recently announced that she will step down from her position. With a change in leadership imminent, we consider the organization’s dual imperative: to protect children during humanitarian crises - including the current COVID-19 crisis-, and to shift from direct service delivery towards support for systems and policies that will drive sustainable improvements in child well-being today and tomorrow.

Beyond Aid: Sources of Finance for Global Health Security

Twenty months into the COVID-19 pandemic, there is broad agreement that more and smarter international financing is needed to respond to the current pandemic and to prepare for the next global health threat.  The G20 independent panel report and this blog, among others, highlight the priorities for the uses and needed characteristics of the funding, but now to the next hard question – how to raise the money?  What are the sources of revenue beyond ODA that could contribute to the proposed Global Health Threats Fund?

C19 Economics site

Three Key Gaps in the Health Economics Research on COVID-19, and Why It Matters

The online platform C19economics was created to support researchers and decision makers by collating the health economic literature published on the COVID-19 pandemic into an easily searchable repository. After reviewing the literature, we found three notable gaps in coverage in terms of geographical focus and topic areas. 

An image of people standing in line waiting for a COVID test.

Better Together: Exploring the Role of Pooled Procurement in Improving Access to Medicines amid COVID-19

Access to safe, effective, and affordable essential medicines is an integral global health goal, and all the more important during a public health emergency like COVID-19. Supply chain inefficiencies, procurement capacity constraints, and financial difficulties impede access to affordable, quality medicines; crises exacerbate these issues.

Pages